IGF1 and malignant colon neoplasm: In conclusion, our results suggest that inhibition of the EGFR signaling pathway in colon cancer cells alters cytokine secretion (e.g. IGF-1) and prevents M1- to M2-like polarization in macrophages, thus inhibiting cancer cell growth (Figure 5).